Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Sunday, July 28, 2024 · 731,159,294 Articles · 3+ Million Readers

SHAREHOLDER ALERT: Morris Kandinov Investigating MYPS, ALDX, LOVE and SKIN; Shareholders are Encouraged to Contact the Firm

/EIN News/ -- SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of PLAYSTUDIOS, Inc., Aldeyra Therapeutics, Inc., The Lovesac Company, and The Beauty Health Company. If you are a current owner of shares of any of these stocks, contact leo@moka.law or call (619) 780-3993.   

PLAYSTUDIOS, Inc. (NASDAQ: MYPS) Accused of Misleading Investors

On March 31, 2024, Judge Richard F. Boulware, II of the United States District Court for the District of Nevada issued an order denying in part the defendants’ motion to dismiss in the pending securities class action against PLAYSTUDIOS, Inc., paving the way for litigation to proceed. Morris Kandinov LLP is investigating possible breaches of fiduciary duties and other violations of law, on behalf of shareholders. To learn more about this investigation and your rights, visit: https://moka.law/case-contact-form/. All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) Accused of Misleading Investors

Morris Kandinov reminds investors that a securities class action lawsuit has commenced on behalf of investors of Aldeyra Therapeutics, Inc. Morris Kandinov is investigating Aldeyra Therapeutics regarding possible breaches of fiduciary duties and other violations of law on behalf of shareholders. To learn more about this investigation and your rights, visit: https://moka.law/case-contact-form/. All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

The Lovesac Company (NASDAQ: LOVE) Accused of Misleading Investors

Morris Kandinov reminds investors that a securities class action lawsuit has commenced on behalf of investors of The Lovesac Company. Morris Kandinov is investigating The Lovesac Company regarding possible breaches of fiduciary duties and other violations of law on behalf of shareholders. To learn more about this investigation and your rights, visit: https://moka.law/case-contact-form/. All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

The Beauty Health Company (NASDAQ: SKIN) Accused of Misleading Investors

Morris Kandinov reminds investors that a securities class action lawsuit has commenced on behalf of investors of The Beauty Health Company. Morris Kandinov is investigating The Beauty Health Company regarding possible breaches of fiduciary duties and other violations of law on behalf of shareholders. To learn more about this investigation and your rights, visit: https://moka.law/case-contact-form/. All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Concerned shareholders are encouraged to contact Leo Kandinov to learn more:

leo@moka.law
(619) 780-3993
moka.law

Morris Kandinov LLP is a national law firm that specializes in recovering investment losses and protecting stockholder rights. We work on contingency (i.e., you do not pay our fees out-of-pocket), and our attorneys have made substantial recoveries for investors in jurisdictions across the country. The firm would be happy to further discuss these matters, and any legal rights or remedies potentially available to you, at no charge.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contact:

Leo Kandinov, Partner
leo@moka.law
619-780-3993
550 West B Street, 4th Floor
San Diego, CA 92101


Primary Logo

Powered by EIN News
Distribution channels: Business & Economy, Law ...


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release